This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Masood, R. Articles by Gill, P. S. Search for Related Content PubMed PubMed Citation Articles by Masood, R. Articles by Gill, P. S.

Interleukin 8 Is an Autocrine Growth Factor and a Surrogate Marker for Kaposi’s Sarcoma¹

University of Southern California Keck School of Medicine, Los Angeles, California 90089-9172

Kaposi’s sarcoma (KS) is the most common tumor associated with HIV-1 infection. Here, we report the expression, regulation, and biological effect of interleukin (IL)-8 in KS. AIDS-KS cell lines expressed higher levels of IL-8 than either human umbilical vein endothelial cells (HUVECs), human aortic smooth muscle (AoSM) cells or fibroblast cells (T1). The inflammatory cytokine IL-1ß up-regulated IL-8 expression in a time- and concentration-dependent manner in KS cell lines. IL-8 antisense oligonucleotides specifically reduced IL-8 mRNA and protein levels and inhibited KS cell growth in a dose-dependent manner. In addition, supernatant from a KS cell line induced the growth of HUVECs and angiogenesis in chicken chorioallantoic membrane assays, both of which were inhibited by IL-8 neutralizing antibody. Serum levels of IL-8 were also elevated in KS cases compared with matched controls. Modulation of IL-8 may thus be of therapeutic value in this disease.

This article has been cited by other articles:

				M. Hsu, S.-Y. Wu, S.-S. Chang, I.-J. Su, C.-H. Tsai, S.-J. Lai, A.-L. Shiau, K. Takada, and Y. Chang Epstein-Barr Virus Lytic Transactivator Zta Enhances Chemotactic Activity through Induction of Interleukin-8 in Nasopharyngeal Carcinoma Cells J. Virol., April 1, 2008; 82(7): 3679 - 3688. [Abstract] [Full Text] [PDF]

				L. Speciale, R. Biffi, R. Mancuso, E. Borghi, R. Mazziotti, and P. Ferrante Big endothelin-1 and interleukin-6 modulation in human microvascular endothelial cells after human herpesvirus 8 infection. Experimental Biology and Medicine, June 1, 2006; 231(6): 1171 - 1175. [Abstract] [Full Text] [PDF]

				I. H. Benoy, R. Salgado, P. Van Dam, K. Geboers, E. Van Marck, S. Scharpe, P. B. Vermeulen, and L. Y. Dirix Increased Serum Interleukin-8 in Patients with Early and Metastatic Breast Cancer Correlates with Early Dissemination and Survival Clin. Cancer Res., November 1, 2004; 10(21): 7157 - 7162. [Abstract] [Full Text] [PDF]

				L. Rosano, F. Spinella, V. Di Castro, M. R. Nicotra, A. Albini, P. G. Natali, and A. Bagnato Endothelin Receptor Blockade Inhibits Molecular Effectors of Kaposi's Sarcoma Cell Invasion and Tumor Growth in Vivo Am. J. Pathol., August 1, 2003; 163(2): 753 - 762. [Abstract] [Full Text] [PDF]

				L. A. Dourmishev, A. L. Dourmishev, D. Palmeri, R. A. Schwartz, and D. M. Lukac Molecular Genetics of Kaposi's Sarcoma-Associated Herpesvirus (Human Herpesvirus 8) Epidemiology and Pathogenesis Microbiol. Mol. Biol. Rev., June 1, 2003; 67(2): 175 - 212. [Abstract] [Full Text] [PDF]

				S. I. Resto-Ruiz, M. Schmiederer, D. Sweger, C. Newton, T. W. Klein, H. Friedman, and B. E. Anderson Induction of a Potential Paracrine Angiogenic Loop between Human THP-1 Macrophages and Human Microvascular Endothelial Cells during Bartonella henselae Infection Infect. Immun., August 1, 2002; 70(8): 4564 - 4570. [Abstract] [Full Text] [PDF]

				R. Masood, E. Cesarman, D. L. Smith, P. S. Gill, and O. Flore Human Herpesvirus-8-Transformed Endothelial Cells Have Functionally Activated Vascular Endothelial Growth Factor/Vascular Endothelial Growth Factor Receptor Am. J. Pathol., January 1, 2002; 160(1): 23 - 29. [Abstract] [Full Text] [PDF]